Clincosm LogoSign in Get a demo

Neuroblastoma

Showing NaN - NaN of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Australia, Canada, United States (DFMO, Celecoxib, Cyclophosphamide)

Active, not recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +12 more
Jan 30, 2023

Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)

Active, not recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +11 more
Jan 30, 2023

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)

Recruiting
  • Neuroblastoma
  • 131I-MIBG
  • +4 more
  • Los Angeles, California
  • +11 more
Jan 30, 2023

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene

Not yet recruiting
  • Synovial Sarcoma
  • +3 more
  • Afamitresgene autoleucel
  • Palo Alto, California
  • +3 more
Dec 6, 2022

Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)

Recruiting
  • Ganglioneuroblastoma
  • Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +18 more
  • Birmingham, Alabama
  • +158 more
Sep 14, 2022

Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • Birmingham, Alabama
  • +83 more
Aug 19, 2022

Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)

Active, not recruiting
  • Ganglioneuroblastoma, Nodular
  • Neuroblastoma
  • Dinutuximab
  • +4 more
  • Mesa, Arizona
  • +77 more
Aug 17, 2022

Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,

Recruiting
  • Ganglioneuroblastoma
  • +3 more
  • Birmingham, Alabama
  • +219 more
Aug 17, 2022

Neuroblastoma Trial in Canada, United States (131I-MIBG, Vincristine, Irinotecan)

Completed
Has Results
  • Neuroblastoma
  • 131I-MIBG
  • +3 more
  • Los Angeles, California
  • +13 more
May 16, 2022

Neuroblastoma Biology Study

Recruiting
  • Neuroblastoma
    • Los Angeles, California
    • +13 more
    May 18, 2022

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022

    Neuroblastoma Precision Trial

    Active, not recruiting
    • Neuroblastoma
    • Gene panel sequencing of tumor specimens
    • Los Angeles, California
    • +10 more
    Feb 16, 2022

    Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma Trial in United States (Enoblituzumab)

    Completed
    • Neuroblastoma
    • +5 more
    • Palo Alto, California
    • +5 more
    Feb 4, 2022

    Neuroblastoma, Neuroectodermal Tumors, Tumors Trial in United States (131I-MIBG, 131-MIBG + Vorinostat)

    Recruiting
    • Neuroblastoma
    • +2 more
    • San Francisco, California
    • +15 more
    Jan 7, 2022

    Neuroblastoma Trial in Worldwide (carboplatin, cyclophosphamide, doxorubicin HCl)

    Completed
    Has Results
    • Neuroblastoma
    • Birmingham, Alabama
    • +188 more
    Jul 1, 2021

    Neuroblastoma Trial in Canada, United States (Bevacizumab, cyclophosphamide, zoledronic acid)

    Completed
    • Neuroblastoma
    • Los Angeles, California
    • +14 more
    Mar 10, 2020

    Immunogenicity and Safety of Unituxin® in High-Risk

    Terminated
    Has Results
    • Neuroblastoma
    • Birmingham, Alabama
    • +17 more
    Jun 11, 2019

    Neuroblastoma Trial in Canada, United States (MLN8237, Irinotecan, Temozolomide)

    Completed
    Has Results
    • Neuroblastoma
    • Los Angeles, California
    • +12 more
    Jul 10, 2019

    Neuroblastoma

    Completed
    • Neuroblastoma
    • Cytology Specimen Collection Procedure
    • +2 more
    • Birmingham, Alabama
    • +152 more
    Jan 4, 2019

    Neuroblastoma Trial in United States (SF1126)

    Terminated
    • Neuroblastoma
    • Los Angeles, California
    • +10 more
    Aug 16, 2018

    Medulloblastoma, Rhabdomyosarcoma, Neuroblastoma Trial in Worldwide (LDE225)

    Completed
    Has Results
    • Medulloblastoma
    • +5 more
    • Atlanta, Georgia
    • +13 more
    Feb 13, 2017

    Neuroblastoma Trial in Worldwide (biological, drug, procedure, radiation)

    Completed
    • Neuroblastoma
    • filgrastim
    • +8 more
    • Birmingham, Alabama
    • +234 more
    Mar 9, 2017

    Neuroblastoma Trial in Canada, United States (fenretinide, high performance liquid chromatography, pharmacological study)

    Completed
    • Neuroblastoma
    • Los Angeles, California
    • +12 more
    Dec 20, 2016